Harrow (HROW) Cost of Revenue (2014 - 2026)
Harrow (HROW) recorded quarterly Cost of Revenue of $17.2 million in Q1 2026, down 7.09% quarter-over-quarter from $18.5 million in Q4 2025, and up 10.53% on a YoY basis from $15.5 million in Q1 2025.
Harrow (HROW) Cost of Revenue (2014 - 2026) Analysis & Trends
Harrow's Cost of Revenue history runs 13 years deep, the most recent figure standing at $17.2 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 10.53% year-over-year to $17.2 million; the TTM figure through Mar 2026 stood at $69.6 million (up 28.32% YoY), while the FY2025 annual figure was $67.9 million, up 37.95% from the prior year.
- Cost of Revenue was $17.2 million for Q1 2026 at Harrow, down from $18.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $18.5 million in Q4 2025 to a low of $6.0 million in Q1 2022.
- Historically, Cost of Revenue has averaged $11.7 million across 5 years, with a median of $11.3 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue soared 83.33% in 2023, then climbed 10.53% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $6.2 million in 2022, then jumped by 83.33% to $11.3 million in 2023, then advanced by 25.07% to $14.1 million in 2024, then soared by 30.65% to $18.5 million in 2025, then declined by 7.09% to $17.2 million in 2026.
- The last three Cost of Revenue figures came in at $17.2 million (Q1 2026), $18.5 million (Q4 2025), and $17.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Harrow | 1.34 Bn | 1.24 Bn | 27.05 Mn | 17.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.16 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 15.52 Mn |
| Mar 31, 2025 | 15.52 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Sep 30, 2024 | 12.02 Mn |
| Sep 30, 2024 | 12.02 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 10.55 Mn |
| Mar 31, 2024 | 10.55 Mn |
| Dec 31, 2023 | 11.30 Mn |
| Dec 31, 2023 | 11.30 Mn |